European Journal of Clinical Pharmacology

, Volume 31, Issue 3, pp 277–280

Treatment of chronic urticaria with terfenadine and ranitidine

A randomized double-blind study in 45 patients
  • E. Paul
  • R. H. Bödeker

DOI: 10.1007/BF00981123

Cite this article as:
Paul, E. & Bödeker, R.H. Eur J Clin Pharmacol (1986) 31: 277. doi:10.1007/BF00981123


45 patients with chronic urticaria were randomized to double blind therapy with terfenadine an H1-antihistamine or ranitidine, an H2-antihistamine, or a combination of both drugs. The therapeutic response was assessed by diary scores. The primary effect variable was “itching”. The inference-statistical evaluation of the patient scores showed varying therapeutic effects. The Type-I error wasp=0.015. Itching was reported to be significantly lower by patients receiving both drugs than by those who were given terfenadine alone, while ranitidine in monotherapy had no significant effect on itching. A similar trend was seen in assessment of the severity of weals, while the treatment regimens had no influence on swelling.

Key words

urticaria terfenadine ranitidine randomized double-blind study therapeutic response 

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • E. Paul
    • 1
  • R. H. Bödeker
    • 2
  1. 1.Zentrum für Dermatologie und Andrologie (Hautklinik)Justus Liebig-Universität GiessenGiessenFederal Republic of Germany
  2. 2.Institut für Medizinische InformatikJustus Liebig-Universität GiessenGiessenFederal Republic of Germany

Personalised recommendations